Roche to Present 46 Abstracts, 12 Orals at ASH Meeting
Roche (OTCQX: RHHBY) will present 46 abstracts, including 12 oral presentations, at ASH…
Roche’s Columvi combo doubles survival in three-year DLBCL study
Roche (RHHBY) reported three-year follow-up from the phase III STARGLO study in relapsed/refractory…